Journal article 646 views 86 downloads
Preterm birth and prescriptions for cardiovascular, antiseizure, antibiotics and antiasthmatic medication in children up to 10 years of age: a population-based data linkage cohort study across six European regions
,
Maria Loane,
Stine Kjær Urhøj,
Elisa Ballardini,
Clara Cavero- Carbonell ,
Alessio Coi,
Laura García-Villodre,
Joanne Emma Given ,
Mika Gissler,
Anna Heino,
Sue Jordan ,
Amanda Neville,
Anna Pierini,
Joachim Tan,
Ieuan Scanlon,
Ester Garne ,
Joan K Morris
BMJ Open, Volume: 12, Issue: 10, Start page: e061746
Swansea University Authors:
Sue Jordan , Ieuan Scanlon
-
PDF | Version of Record
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license
Download (971.09KB)
DOI (Published version): 10.1136/bmjopen-2022-061746
Abstract
Objectives Preterm children are exposed to many medications in neonatal intensive care units, but little is known about the effect of prematurity on medication use throughout infancy and childhood. We examined prescriptions of cardiovascular medication (CVM), antiseizure medication (ASM), antiasthma...
| Published in: | BMJ Open |
|---|---|
| ISSN: | 2044-6055 2044-6055 |
| Published: |
BMJ
2022
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa61953 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract: |
Objectives Preterm children are exposed to many medications in neonatal intensive care units, but little is known about the effect of prematurity on medication use throughout infancy and childhood. We examined prescriptions of cardiovascular medication (CVM), antiseizure medication (ASM), antiasthmatic medication and antibiotics issued/dispensed in the first 10 years of life for very and moderately preterm children compared with term.Design Population-based data linkage cohort study linking information from birth records to prescription records.Setting Six registries from five countries in the EUROlinkCAT study.Participants The study population included 1 722 912 children, of whom 10 820 (0.6%) were very preterm (<32 weeks gestational age (GA)), 92 814 (5.4%) were moderately preterm (32–36 weeks GA), 1 606 643 (93.3%) were born at term (≥37 weeks GA) and 0.7% had missing GA. Children with major or minor congenital anomalies were excluded (including patent ductus arteriosus).Main outcome measures Relative risk (RR) of receiving a prescription for CVM, ASM, antiasthmatic and antibiotics.Results Very preterm children had a higher RR of receiving a prescription for CVM and ASM than preterm children. For all preterm children, the RR of having a CVM prescription was 3.58 (95% CI 2.06 to 6.23); 2.06 (95% CI 1.73 to 2.41) for ASM; 1.13 (95% CI 0.99 to 1.29) for antiasthmatics and 0.96 (95% CI 0.93 to 0.99) for antibiotics in the first year of life. Increased prescription of CVM, ASM and antiasthmatics persisted for all 10 years of follow-up. Although the RR was highest for CVM and ASM, in absolute numbers more children received prescriptions for antibiotics (42.34%, 95% CI 38.81% to 45.91%) and antiasthmatics (28.40%, 95% CI 16.07% to 42.649%) than for CVM (0.18%, 95% CI 0.12% to 0.25%) and ASM (0.16%, 95% CI 0.13% to 0.20%) in the first year of life.Conclusion Preterm children had a higher risk of being prescribed/dispensed CVM, ASM and antiasthmatics up to age 10. This study highlights a need for further research into morbidity beyond age 10. |
|---|---|
| College: |
Faculty of Medicine, Health and Life Sciences |
| Funders: |
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 733001. |
| Issue: |
10 |
| Start Page: |
e061746 |